Evans Electric IPO vs Par Drugs IPO

Comparison between Evans Electric IPO and Par Drugs IPO.

IPO Details

Evans Electric IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Evans Electric IPO is up to ₹1.83 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Evans Electric IPO is ₹52.00 per share and of Par Drugs IPO is ₹51.00 per share.

 Evans Electric IPOPar Drugs IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹52.00 per share₹51.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size2000 shares2000 shares
Fresh Issue Size3,52,000 shares15,88,000 shares
Fresh Issue Size (Amount)up to ₹1.83 Crup to ₹8.10 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total3,52,000 shares15,88,000 shares
Issue Size Total (Amount)up to ₹1.83 Crup to ₹8.10 Cr

IPO Timetable

Evans Electric IPO opens on Apr 30, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Evans Electric IPO and Par Drugs IPO is May 03, 2019, and May 08, 2019, respectively.

 Evans Electric IPOPar Drugs IPO
Issue OpenApr 30, 2019May 03, 2019
Issue CloseMay 03, 2019May 08, 2019
Basis Of Allotment (Tentative)May 08, 2019May 13, 2019
Initiation of Refunds (Tentative)May 09, 2019May 14, 2019
Credit of Share (Tentative)May 10, 2019May 15, 2019
Listing date (Tentative)May 13, 2019May 16, 2019

Financials & KPIs

Evans Electric IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .

 Evans Electric IPOPar Drugs IPO
Financials

Company Financials (Restated)

Period Ended31 Oct 201831 Mar 201831 Mar 201731 Mar 2016
Assets8.738.409.495.60
Total Income4.005.8710.725.12
Profit After Tax0.580.462.370.41
EBITDA1.041.073.760.85
NET Worth7.657.076.674.43
Reserves and Surplus7.156.576.173.93
Total Borrowing0.480.06
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)80%99.55%
Promoter Shareholding (Post-Issue)58.31%72.5%
Market Cap₹7.13 Cr.₹31.38 Cr.

Shares Offered

In the Evans Electric IPO Retail Individual Investors (RII) are offered 1,76,000 shares while in Par Drugs IPO retail investors are offered 1,76,000 shares. Qualified Institutional Buyers (QIB) are offered in Evans Electric IPO and in Par Drugs IPO.

 Evans Electric IPOPar Drugs IPO
Market Maker Reservation20,000 shares84,000 shares
NII1,76,000 shares7,78,000 shares
RII1,76,000 shares7,80,000 shares
Employee30,000 shares
Total3,52,000 shares15,88,000 shares

Bids Received (Subscription)

Evans Electric IPO subscribed 1.59x in total, whereas Par Drugs IPO subscribed 5.64x.

 Evans Electric IPOPar Drugs IPO
NII (times)2.62x3.48x
RII (times)0.56x7.97x
Employee (times)1.00x
Total (times)1.59x5.64x

Compare with others

Compare:

Evans Electric IPO Vs Par Drugs IPO